全部| 求助中| 待确认 按时间排序|按积分排序

Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors

用户6X7Ch8WUQ_gI 14天前 10 已完结

Discovery of a Novel MNK Inhibitor (NSP-1047) with In Vivo Anti-acute Myeloid Leukemia Activity

用户6X7Ch8WUQ_gI 14天前 10 已完结

Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein–Protein Interaction

用户6X7Ch8WUQ_gI 14天前 10 已完结

Alirocumab versus Evolocumab on Cardiovascular Outcomes: A Systematic Review and Meta-analysis

用户k7g3AjDeE8DM 14天前 10 已关闭

Development of an RXR Agonist Scaffold with Pronounced Homodimer Preference

用户6X7Ch8WUQ_gI 14天前 10 已完结

Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial

用户k7g3AjDeE8DM 14天前 10 已完结

Overcoming E3 Ligase-Mediated Resistance: Development of Novel Hydrophobic Tagging-Based Degraders Targeting ALK Protein

用户6X7Ch8WUQ_gI 14天前 10 已完结

Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations

用户mKQO0T3T2ANY 14天前 10 已完结

Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery

用户mKQO0T3T2ANY 14天前 10 已完结

In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration

用户uXKlPLrO8Jz4 14天前 10 已完结
首页 上页 51 52 53 54 55 56 57 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com